The Week Ahead: COS...
Health Care: Drugs
Alexion Pharmaceuticals Inc. (ALXN: NASDAQ)
$99.17 -0.71 | -0.71%
05/24/13 - 04:00 PM ET
Portfolios with ALXN
- Portfolio NameUser Type
- User5 S&P 500 stocks poised for...
- ProNavellier & Associates
- UserGFNN Stockdiagnostics 27
- ContributorRocket Stocks for the Week ...
- UserRenzo's portfolio
- UserBender
- UserGFNN Stockdiagnostics 18
- Contributor10 Stocks of Top-Performing...
- UserMoney Making Machine
- UserGFNN Stockdiagnostics 17
Latest ALXN Headlines from TheStreet
- Notable Two Hundred Day Moving Average Cross - ALXN 05.23.13 | 12:05 pm
- 5 Stocks Underperforming Today In The Drugs Industry 05.20.13 | 01:05 pm
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Laggard 05.16.13 | 05:05 pm
- 3 Stocks Underperforming Today In The Drugs Industry 05.15.13 | 01:05 pm
- Cramer: Biotech Makes a Comeback 05.10.13 | 04:05 pm
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner 05.09.13 | 05:05 pm
- Raptor's FDA Approval Is New Test For Orphan Drug Pricing 05.01.13 | 07:05 am
- ALXN Makes Bullish Cross Above Critical Moving Average 04.25.13 | 04:04 pm
- Alexion Rises On Unusually High Volume (ALXN) 04.25.13 | 04:04 pm
- Big-Cap Biotech Earnings Calm Investor Nerves (Update) 04.25.13 | 10:04 am
Press Releases for ALXN
- Alexion Joins The International Federation Of Kidney Foundations In Celebrating World Kidney Day 2013 - Business Wire 03.14.13 | 06:03 am
- Alexion To Present At The Barclays Global Healthcare Conference - Business Wire 03.05.13 | 10:03 am
- Alexion Joins Eurordis, NORD And Patient Organizations Worldwide In Celebrating Rare Disease Day 2013 - Business Wire 02.28.13 | 06:02 am
- Alexion To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 10:02 am
- Alexion Reports Fourth Quarter And Full Year 2012 Results - Business Wire 02.14.13 | 06:02 am
- Alexion Recommends Rejection Of Mini-Tender Offer By TRC Capital Corporation - Business Wire 02.07.13 | 06:02 am
- Alexion Pharmaceuticals To Report Fourth Quarter And Full Year 2012 Results On Thursday, February 14, 2013 - Business Wire 01.31.13 | 10:01 am
- Alexion To Present At The JP Morgan 31st Annual Healthcare Conference - Business Wire 01.02.13 | 10:01 am
- New Data Highlighting Long-Term Efficacy And Safety Outcomes Of PNH Patients Treated With Soliris® Reported At ASH Annual Meeting - Business Wire 12.10.12 | 10:12 am
- Alexion To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.21.12 | 10:11 am
Partner Headlines for ALXN
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- Market Close Report: NASDAQ Composite index closes at 3,239.17 down -28.35 points - NASDAQ 04.01.13 | 08:04 pm
- Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy - NASDAQ 03.14.13 | 04:03 pm
- Market Close Report: NASDAQ Composite index closes at 3,182.03 up 12.29 points - NASDAQ 03.04.13 | 09:03 pm
- Trouble At A Stock's Breakout Could Be Sell Signal - Investor's Business Daily 03.04.13 | 05:03 pm
- Following The Leaders Is Way To Reap Windfall Profits - Investor's Business Daily 02.22.13 | 04:02 pm
- Market Close Report: NASDAQ Composite index closes at 3,131.49 down -32.92 points - NASDAQ 02.21.13 | 09:02 pm
- Market Close Report: NASDAQ Composite index closes at 3,213.59 up 21.56 points - NASDAQ 02.19.13 | 09:02 pm
- Pre-Market Earnings Report for February 14, 2013 : PEP, GM, APA, ABX, DTV, CVE, PPL, ALXN, SLF, WM, REGN, ECA - NASDAQ 02.13.13 | 09:02 pm
- Raptor To Rise On Proven Strategy & Upcoming FDA Decision - Seeking Alpha 12.28.12 | 09:12 am
